anti10a Levels in Women Treated With LMWH in the Postpartum Period
Status:
Not yet recruiting
Trial end date:
2022-02-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to compare between anti-10a levels in postpartum women receiving
different prophylactic doses of LMWH: one group with LMWH doses adjusted by the women's
weight and the second group receiving 1mg/kg to a maximum dose of 120 mg